gastric cancer and colorectal cancer
Conditions
Interventions
Gold Standard:cytology
Index test:CellCollector technology (CEA as marker), qPCR technology (CEA, lncRNA-GC1, GMAN, HOTTIP, SNHG1, NEAT1, SNHG6 and CCAL as markers)
Sponsors
Gastrointestinal Surgery Department,Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with gastric or rectal cancer confirmed by pathology in our hospital or other hospitals; no distant metastasis confirmed by preoperative imaging and feasible radical resection; no preoperative neoadjuvant radiotherapy; no other major underlying diseases; no comorbidities such as preoperative obstruction, bleeding or perforation.
Exclusion criteria
Exclusion criteria: Combination of other malignant tumors or previous history of malignant tumors; current history of uncontrollable infections or combination of major systemic diseases; distant metastases detected by preoperative imaging or intraoperative exploration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraperitoneal free cancer cells;sensitivity;specificity;area under roc curve(AUC); | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive Predictive Value;negative predictive value; | — |
Countries
China
Contacts
Public ContactJianping Gong
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Outcome results
None listed